共 44 条
- [1] Raman JD(2007)Management of patients with upper urinary tract transitional cell carcinoma Nat Clin Pract Urol 4 432-443
- [2] Scherr DS(1998)Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients Urology 52 594-601
- [3] Hall MC(1998)Adjuvant chemotherapy for high-risk urothelial transitional cell carcinoma: the Princess Margaret Hospital experience Br J Urol 82 366-372
- [4] Womack S(2006)Adjuvant chemotherapy in the management of pT3N0M0 transitional cell carcinoma of the upper urinary tract Urol Int 77 22-26
- [5] Sagalowsky AI(2009)Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration J Urol 182 900-906
- [6] Michael M(2009)Revised equations for estimated GFR from serum creatinine in Japan Am J Kidney Dis 53 982-992
- [7] Tannock IF(2010)Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy Cancer 15 2967-2973
- [8] Czaykowski PM(2004)The impact of tumor location on prognosis of transitional cell carcinoma of the upper urinary tract J Urol 171 621-625
- [9] Lee SE(2010)Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma Urology 75 328-332
- [10] Byun SS(2004)Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced carcinoma of the upper urinary tract: a study by the Hellenic Cooperative Oncology Group J Clin Oncol 22 2150-2154